COVID-19 Information and Resources
We're continuing to support health professionals during COVID-19, keeping you updated with the latest information and resources.
COVID-19 Risk Stratification Table
To support centres during NHS Phase II COVID-19 Planning, we have produced a prostate cancer risk stratification table that sets out which men should be diagnosed, treated and monitored as a priority and within what timescale.
The table has been based on initial EAU COVID-19 guidance, but also details the most robust and up-to-date evidence underpinning their recommendations, where available. Where evidence is limited, Prostate Cancer UK will seek guidance from clinical experts and we expect to update this table to include their input and any changes in NHS Guidance. The table also outlines relevant NICE recommendations.
Supporting the Optimal Timed Diagnostic Pathway
Leading clinicians across England were brought together by Prostate Cancer UK and NHS England to develop guidance to supplement the Optimal Timed Pathway for Prostate Cancer Diagnosis, produced by NHS England
COVID-19 now requires the prostate cancer diagnostic pathway to evolve so that it can be delivered with minimal COVID-19 risk. We believe this makes this clinically led guidance more important than ever at ensuring prostate cancer diagnostic services are triaged for men at higher than average risk of the disease and that biopsy techniques avoid COVID-19 and sepsis infections.
Delivering bad news over the telephone during COVID-19
Across the NHS telephone consultations are temporarily replacing face to face clinics due to COVID-19. Our Specialist Nurses have developed a quick checklist to support you to support patients when informing them of a new diagnosis or disease progression over the telephone.
Support for patients
Our Specialist Nurses are available via telephone, email and live chat online to respond to any queries or concerns from men, and their loved ones, about prostate disease and COVID-19.
We're also regularly updating our information about COVID-19 and prostate cancer to support you and your patients. Read our FAQs here.
Please get in touch with us if you have any questions or we can help in any way.